AlliSya Preferred Medical

AlliSya Preferred Medical is a Sharia-individual-health flagship from Allianz Life Syariah Indonesia, structured as a three-tier annual indemnity hospitalisation plan (Standard, Extra, Premier) with annual benefit limits stepping from Rp 1 billion to Rp 20 billion and geographic scope stepping from Indonesia-only to Asia-plus-Australia. Distinctive structural elements include a Preferred Network vs Other Network deductible system (Risiko Sendiri Opsi 1 / Opsi 2) that ties co-payment amounts to hospital category, a Rp 100 million aggregate per year cap on Penyakit Khusus claims after a 6-month waiting period, an embedded Tambahan annual benefit limit triggered by heart attack / stroke / invasive cancer (effectively doubling the annual cap for these three conditions), and a 5% Hemat Kontribusi renewal discount for no-claim auto-debit customers.

Category: health (Conventional + Syariah indemnity hospital plans treated as one market per project convention) Products in category analyzed: 35 catalogued (~14 with extracted PDFs as of 2026-04-27) This product’s position: Premium-tier Syariah indemnity plan with very high annual limits (Rp 20 bn Premier) and a network-tiered co-payment structure; positioned as the Sharia-counterpart to the conventional Allianz Preferred Medical for upper-middle and affluent agency customers.

A “typical” Indonesian individual indemnity health product in this inventory offers 1–3 plan tiers, an annual room-and-board cap, an inner-limit benefit table, an annual policy term that auto-renews to a stated maximum age (most commonly 70–85), an Indonesia or Indonesia+ASEAN coverage area, and a deductible/co-payment of some form. AlliSya Preferred Medical sits in the upper end on annual limit, geographic scope, and the sophistication of its co-payment design.

Quantifiable benchmarking across the health category remains limited because most peer products’ detailed extraction is HTML-only (Path A) and benefit-table specifics are PDF-locked. The table below is qualitative-comparative based on observed structures in the inventory, with anchor figures from this RIPLAY.

[Limited quantitative benchmarking available — category data coverage is roughly 40% on PDF and most line-item benefit numbers fall below the 60% coverage threshold. Analysis relies more heavily on qualitative observations below.]

Quantifiable position summary: On annual limits, geographic reach, daily room caps, and entry/renewal age, AlliSya Preferred Medical positions at the top of the catalogued category. Its Penyakit Major Tambahan annual limit (an extra Rp 20 bn triggered by serious cancer, stroke, or heart attack) and its tiered network/geography deductible matrix are unusually sophisticated for a Sharia-segment product and differentiate it from simpler peers.

• Penyakit Major Tambahan annual limit effectively doubles cover for the three claims that bankrupt families — Plan Premier’s annual cap is Rp 20 billion, plus a separate Tambahan annual limit of another Rp 20 billion triggered specifically by heart attack, stroke, or invasive cancer. These three conditions account for the majority of catastrophic medical-cost events in Indonesia. The Tambahan structure means the effective ceiling for the most likely catastrophic-cost scenarios is Rp 40 billion at Premier — a level no other catalogued Syariah product matches and one of the highest in the conventional inventory as well.
• Network-tiered Risiko Sendiri offers customer-controllable cost-sharing — Plan Premier’s Opsi 1 deductible is Rp 6 million at Preferred Network in Indonesia, Rp 12 million at Other Network in Indonesia, Rp 12 million in Asia ex-SG/HK/JP, and Rp 25 million in SG/HK/JP/Australia; Opsi 2 doubles those amounts. Customers who treat at preferred Indonesian hospitals see materially lower out-of-pocket exposure, which gives the agent a constructive cost-management conversation rather than a single take-it-or-leave-it deductible.
• Geographic reach extending to Asia + Australia at Premier — Premier’s coverage including Australia is rare among the catalogued domestic peers, which mostly stop at Indonesia or ASEAN. This is meaningful for affluent customers who travel for cancer or cardiac treatment to Singapore, Australia, or Japan — and the Extra tier’s Asia-only coverage (excluding the three most expensive geographies of SG, HK, JP) gives customers a sensible step-down option without losing cross-border coverage entirely.
• Sharia structural compliance with credible substance — Tabarru’ fund segregation, Wakalah bil Ujrah contract, Surplus Underwriting returned to the Tabarru’ pool rather than retained as profit, and Allianz Life Syariah’s status as a stand-alone OJK-licensed Syariah entity since 2023 provide a credible structural answer to Sharia-conscious customers, rather than a label slapped onto a conventional product.

• Plan Standard is heavily exclusion-loaded versus Extra/Premier — The Standard tier explicitly excludes home care, traditional medicine, advanced rehabilitation, durable medical equipment, artificial limbs, palliative care, HIV/AIDS treatment, organ transplant, and the Expert Medical Opinion / Medical Assistance services. Penyakit Khusus is not covered in Year 1 at Standard, only from the renewal year onward. This creates a meaningful “bait-and-disclose” risk in the field if agents underplay how different Standard’s protection is from the Extra/Premier benefit headlines typically used in marketing materials.
• No premium tables or sample contributions disclosed in the public RIPLAY — Unlike the conventional Allianz Preferred Medical brochure (which discloses a sample annual premium of Rp 18.83 million for a 30-year-old Plan Premier), AlliSya Preferred Medical’s public RIPLAY does not disclose absolute Rupiah figures for Tabarru’ or Ujrah, marking the table cells as “Xx% / Yy% / Zz%”. This forces every prospect into a quote conversation with an agent before they can compare price, weakening the digital-discovery funnel that increasingly drives upper-funnel research in Indonesia’s middle class.
• Penyakit Khusus aggregate cap of Rp 100 million per year is relatively low — During the 6-month coverage window after the 6-month waiting period (Year 1), Penyakit Khusus claims (which include common conditions like hypertension, hyperlipidemia, kidney/gallbladder stones, gallbladder disease, fibroids, peptic ulcer, hernia, hemorrhoids, and benign tumours) are capped at Rp 100 million in aggregate per year across all plans. For a customer who develops a covered Penyakit Khusus that requires hospitalisation, this cap is well below the headline annual limits and may surprise customers who read only the Rp 20 billion top-line.
• Annual policy with inflation-exposed renewal pricing — As an annual indemnity product, the contract gives the insurer the right to re-rate at every renewal. With Indonesian medical inflation projected near 13.6% in 2026 (brochure-cited Mercer Marsh source) and the new POJK 36/2025 co-payment regime expected to compress insurer claims ratios only partially, customers face material renewal-premium uncertainty. The 5% Hemat Kontribusi renewal discount softens but does not offset double-digit re-rating.

- POJK 36/2025 co-payment regime favours already-structured products — From January 2026 every Indonesian health insurance policy must include a 10% co-payment with caps of Rp 300,000 outpatient / Rp 3,000,000 inpatient and a Medical Advisory Board (DPM). AlliSya Preferred Medical’s existing Risiko Sendiri framework is structurally aligned and more granular than typical peers — so re-papering effort is small and Allianz Syariah can market continuity while peers are re-issuing policies through 2026.

- Indonesia’s Sharia insurance penetration remains low and is growing — OJK roadmap data and Indonesia Insurance Statistics show Sharia insurance gross contribution in single-digit percentages of total industry premium, with growth rates outpacing conventional in recent years. Allianz Life Syariah’s stand-alone OJK-licensed entity (operational from 2023) gives it a multi-year head-start on the spin-off compliance other Sharia windows are still navigating, and AlliSya Preferred Medical is the entity’s premium-tier flagship to ride that growth.

- Indonesian medical inflation reinforces high-limit positioning — With medical inflation tracking ~13.6% domestically, the value proposition of a Rp 20 billion annual cap (Rp 40 billion effective with the Tambahan) strengthens each year. This is exactly the macro tailwind that supports premium-tier indemnity plans over basic hospital cash plans, especially among the 30–55 age cohort that has earnings to protect.

- Bundling with Sharia investment-linked or savings products — Because the product carries an embedded Rp 30 million death benefit, it can be sold next to one of Allianz Syariah’s investment-linked or savings products as the family medical-shield component without overlapping the life-cover space. This bundle plays well against Sharia bancassurance offerings that push standalone Tabarru’-based hospital cash plans without comparable life-cover integration.

—

- Co-payment compliance levels the field for laggards — POJK 36/2025 forces every competitor (Sun Life Syariah, Prudential Syariah, Manulife Syariah, AXA Mandiri Syariah) to add co-payment by January 2026 — meaning AlliSya Preferred Medical’s tiered Risiko Sendiri design becomes structurally less differentiated by mid-2026. Competitors that re-launch with cleaner, simpler co-payment UX may neutralise this advantage in the agent narrative within 6–12 months.

- Bancassurance distribution pressure on premium-tier Sharia health — Bank Syariah Indonesia (BSI), CIMB Niaga Syariah, and Permata Syariah increasingly push their own captive insurer products through their channels with annual limits in the Rp 5–10 billion range and lower retail prices. As affluent Sharia depositors are a primary target for premium-tier Sharia plans, this distribution overlap may compress agency conversion in the upper-affluent segment.

- DPM (Medical Advisory Board) and utilisation-review cost pressure on Tabarru’ fund — POJK 36/2025 mandates a Medical Advisory Board and stronger utilisation review across every insurer. Compliance cost is borne by the insurer, but is highly likely to be priced into renewal premiums via Tabarru’ contribution increases. If renewal increases at Allianz Syariah cluster above 12–15% in 2026, churn risk to lower-tier products and self-insurance rises among the price-sensitive top-half of the customer base.

- Strong competition from Prudential Syariah PRUSolusi Sehat Syariah on annual limit narrative — Prudential Syariah’s flagship hospital plan also offers high-limit and broad geographic coverage with a strong agency-network distribution. To the extent that customer research increasingly happens digitally before agent meetings (per OJK’s digital-channel push), AlliSya Preferred Medical’s agency-only distribution loses some upper-funnel share to bancassurance/digital channels that surface comparison information sooner.

—

• The dual-cap Tambahan structure (Rp 20 bn + Rp 20 bn for heart attack / stroke / invasive cancer at Premier) is the single most differentiated structural feature in this product and a stronger headline than the simple “Rp 20 bn annual limit” of competitors. It is a directly comparable feature in agent conversations and should anchor the Premier-tier pitch.
• AlliSya Preferred Medical and AlliSya Flexi Medical are stable-mate Sharia health products with overlapping but not identical positioning: Preferred Medical leans into network-tiered cost-sharing and the Tambahan critical-condition top-up, while Flexi Medical leans into the Flexi Benefit no-claim accumulation. Legacy Income’s Allianz Syariah agents should understand which product is the better fit per customer rather than defaulting to one.
• For Legacy Income’s positioning: this product’s main value to agents is a “premium-tier Syariah benchmark” — a way to anchor customer conversations at the top of the Sharia health market when the eventual sold product is something simpler and lower-priced. The Rp 40 billion effective annual ceiling for catastrophic events is the most quotable headline number in the catalogued Syariah inventory.

High-confidence elements (drawn directly from RIPLAY/brochure documents):

• Three plan tiers (Standard, Extra, Premier) with annual limits Rp 1 bn / Rp 15 bn / Rp 20 bn
• Tambahan annual limit equal to base annual limit, triggered by heart attack, stroke, or invasive cancer
• Geographic coverage Indonesia (Standard) / Asia ex SG/HK/JP (Extra) / Asia + Australia (Premier)
• Death benefit Rp 30 million (rising to Rp 45 million from age 80)
• Daily room cap Rp 700K (Standard) / Rp 1,300K (Extra) / Rp 1,650K (Premier)
• Entry age 1 month – 75 years (insured); minimum 18 years (participant); renewal to age 100 (insured), to age 99 (participant contribution)
• Risiko Sendiri Opsi 1: Rp 6M Preferred Network IDN, Rp 12M Other Network IDN, Rp 12M Asia ex-SG-HK-JP, Rp 25M SG/HK/JP/AUS (Premier)
• Risiko Sendiri Opsi 2: doubled vs Opsi 1
• Penyakit Khusus aggregate cap Rp 100 million per year for Year 1 (after 6-month waiting period)
• Cancer 3-month elimination period; Penyakit Khusus and HIV/AIDS 6-month waiting; general illness 30-day waiting
• Embedded major-illness benefits: cancer (Standard Rp 80M, Extra/Premier per bill), dialysis (Standard Rp 15M, Extra/Premier per bill), organ transplant + donor (Extra/Premier per bill), palliative Rp 250 million/year (Extra/Premier), HIV/AIDS Rp 15 million/year (Extra/Premier)
• 5% Hemat Kontribusi renewal discount for no-claim period and auto-debit
• Surplus Underwriting on Tabarru’ fund returned to Tabarru’ fund

Inferred elements (reasoned but not document-backed):

• Position as “premium-tier” rather than mass-market — based on benefit ceilings and geographic scope; no Rupiah price illustration available in RIPLAY
• Comparative position against the rest of the 35-product category — the per-product database is incomplete (~40% PDF coverage)
• Agency-channel-only distribution — confirmed in RIPLAY (Allianz Star Network); bancassurance variants may exist but not stated
• Sharia-conscious affluent middle class as the primary target segment

Data gaps (relevant information not available in source documents):

• No sample annual contribution illustrations (no age/gender/plan price points; RIPLAY shows allocation table cells as Xx% / Yy% / Zz%)
• Specific Risiko Sendiri amounts at Standard tier (RIPLAY shows “-” for Standard in the Risiko Sendiri table — suggesting different mechanics for the entry tier that are not explicit)
• Underwriting requirements thresholds (medical exam, financial questionnaire triggers)
• Annual claim ratio, persistency, and renewal-rate experience
• Comparison against the conventional sibling Allianz Preferred Medical’s pricing differential
• Ujrah Pengelolaan Dana Tabarru’ (asset management fee) — RIPLAY discloses the right to charge but not the rate
• Daily inpatient sub-limits across Standard tier (some line items show specific Standard amounts like Biaya Pembedahan Rp 60 million, others show “-” suggesting absence rather than per-bill)

Extraction quality: medium — RIPLAY extracted to ~700+ lines of clean text; benefit table fine-print readable but plan-tier columns occasionally misaligned in extracted text and require visual verification against the PDF.

This analysis is generated by AI and may contain mistakes. Please exercise discretion.